120 related articles for article (PubMed ID: 38193650)
1. Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan.
Nakanishi S; Fukushima Y; Inokuchi J; Hakariya T; Kakinoki H; Enokida H; Chikui K; Matsuoka H; Shin T; Mukai S; Kamba T; Eto M; Imamura R; Noguchi M; Igawa T; Haga N; Kamoto T; Fujimoto N; Saito S
Int J Urol; 2024 May; 31(5):484-491. PubMed ID: 38193650
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.
Tőke J; Uhlyarik A; Lohinszky J; Stark J; Huszty G; Micsik T; Borka K; Reismann P; Horányi J; Igaz P; Tóth M
Front Endocrinol (Lausanne); 2022; 13():952418. PubMed ID: 36246926
[TBL] [Abstract][Full Text] [Related]
3. The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study.
Sada A; Foster TR; Al-Ward R; Sawani S; Charchar H; Pishdad R; Ben-Shlomo A; Dy BM; Lyden ML; Bergsland E; Jasim S; Raj N; Shank JB; Hamidi O; Hamrahian AH; Chambô JL; Srougi V; Fragoso MC; Graham PH; Habra MA; Bancos I; McKenzie TJ
Surgery; 2024 Jan; 175(1):80-89. PubMed ID: 37945477
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report.
Ohashi K; Hayashi T; Sakamoto M; Iuchi H; Suzuki H; Ebisawa T; Tojo K; Sasano H; Utsunomiya K
BMC Endocr Disord; 2016 Jan; 16():3. PubMed ID: 26772981
[TBL] [Abstract][Full Text] [Related]
5. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.
Hundahl SA; Phillips JL; Menck HR
Cancer; 2000 Feb; 88(4):921-32. PubMed ID: 10679663
[TBL] [Abstract][Full Text] [Related]
6. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades.
Calissendorff J; Calissendorff F; Falhammar H
BMC Endocr Disord; 2016 Mar; 16():15. PubMed ID: 26984275
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
J Am Coll Surg; 2016 Apr; 222(4):480-90. PubMed ID: 26775162
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma: Single center experience.
Şişman P; Şahin AB; Peynirci H; Cander S; Gül ÖÖ; Ertürk E; Ersoy C
Turk J Urol; 2017 Dec; 43(4):462-469. PubMed ID: 29201509
[TBL] [Abstract][Full Text] [Related]
10. Real-world treatment outcomes of patients with penile cancer in the Kyushu-Okinawa area of Japan in the pre-guideline era.
Yamaguchi T; Goya M; Higashijima K; Tobu S; Sato R; Tatarano S; Mukai S; Uemura KI; Tatsugami K; Tsubouchi K; Shida Y; Ishii T; Sakai H; Matsuoka H; Haga N; Eto M; Igawa T; Kamoto T; Enokida H; Shin T; Noguchi M; Fujimoto N; Saito S; Kamba T
Jpn J Clin Oncol; 2023 Aug; 53(9):837-844. PubMed ID: 37282601
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.
Renaudin K; Smati S; Wargny M; Al Ghuzlan A; Aubert S; Leteurtre E; Patey M; Sibony M; Sturm N; Tissier F; Amar L; Bertherat J; Berthozat C; Chabre O; Do Cao C; Haissaguerre M; Pierre P; Briet C; Vezzosi D; Lifante JC; Pattou F; Mirallie E; Baudin E; Cariou B; Libe R; Drui D;
Mod Pathol; 2018 Nov; 31(11):1708-1716. PubMed ID: 29921900
[TBL] [Abstract][Full Text] [Related]
13. Change of treatment modality and outcomes of adrenocortical carcinoma: a retrospective review of single tertiary center experience over 24 years.
Rah CS; Cho JW; Kim WW; Lee YM; Chung KW; Koh JM; Lee SH; Lee JL; Song DE; Hong SJ; Sung TY
Gland Surg; 2022 Oct; 11(10):1615-1627. PubMed ID: 36353581
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.
Terzolo M; Fassnacht M; Perotti P; Libé R; Kastelan D; Lacroix A; Arlt W; Haak HR; Loli P; Decoudier B; Lasolle H; Quinkler M; Haissaguerre M; Chabre O; Caron P; Stigliano A; Giordano R; Zatelli MC; Bancos I; Fragoso MCBV; Canu L; Luconi M; Puglisi S; Basile V; Reimondo G; Kroiss M; Megerle F; Hahner S; Kimpel O; Dusek T; Nölting S; Bourdeau I; Chortis V; Ettaieb MH; Cosentini D; Grisanti S; Baudin E; Berchialla P; Bovis F; Sormani MP; Bruzzi P; Beuschlein F; Bertherat J; Berruti A
Lancet Diabetes Endocrinol; 2023 Oct; 11(10):720-730. PubMed ID: 37619579
[TBL] [Abstract][Full Text] [Related]
15. Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database.
Baechle JJ; Marincola Smith P; Solórzano CC; Tran TB; Postlewait LM; Maithel SK; Prescott J; Pawlik T; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Shirley LA; Fields RC; Jin L; Abbott DE; Ronnekleiv-Kelly S; Sicklick JK; Yopp A; Mansour J; Duh QY; Seiser N; Votanopoulos K; Levine EA; Poultsides G; Kiernan CM
Ann Surg Oncol; 2021 Oct; 28(11):6551-6561. PubMed ID: 33586069
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma: Pediatric aspects (Review).
Sandru F; Petca RC; Carsote M; Petca A; Dumitrascu MC; Ghemigian A
Exp Ther Med; 2022 Apr; 23(4):287. PubMed ID: 35317446
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
Guelho D; Paiva I; Vieira A; Carrilho F
Endocrinol Nutr; 2016 May; 63(5):212-9. PubMed ID: 26969077
[TBL] [Abstract][Full Text] [Related]
18. Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.
Evanoff JD; Patel SG; Hickey KJ; Rensing AJ
J Pediatr Urol; 2021 Oct; 17(5):735.e1-735.e6. PubMed ID: 34210620
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical Carcinoma in Eight Children: A Report and Literature Review.
Li J; Zhang W; Hu H; Zhang Y; Wen Y; Huang D
Cancer Manag Res; 2021; 13():1307-1314. PubMed ID: 33603476
[TBL] [Abstract][Full Text] [Related]
20. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
